BioSpace News Archive

Policy

Government of Canada Supports Initiatives to End Gender-based Violence

Projects to help prevent teen and youth dating violence and child maltreatment

December 3, 2018
·
5 min read
Business

TRIGR Therapeutics Expands Bispecific Immuno-Oncology Pipeline with Exclusive Global License of Clinical Stage, Dual Angiogenesis Inhibitor from ABL Bio

TRIGR to lead clinical development of TR009, a dual VEGF/DLL4 BsAb showing early single agent activity in heavily pretreated, Avastin® and immunotherapy refractory patients with solid tumors

December 3, 2018
·
5 min read
BioMidwest

Season of Joy? Actually, Season of Stress for 88 Percent of Americans

New Survey Finds Family Disagreements, Long To-do Lists and Indulgent Foods Take Emotional and Physical Toll During the Holiday Season

December 3, 2018
·
5 min read
FDA

Vybion Receives Orphan Drug Designation for INT41 in Huntington’s Disease

INT41 is the Company’s Intrabody delivered with AAV for the treatment of Huntington’s disease.

December 3, 2018
·
3 min read
Drug Development

Amphivena Presents at ASH First-in-Human Phase 1 Clinical Data on AMV564

Data Demonstrate AMV564’s Safety, Anti-Leukemic Activity, and Unique PK Profile

December 3, 2018
·
2 min read
FDA

JenaValve Technology Receives FDA Approval for Expanded IDE Enrollment in the Treatment of Patients with Severe Aortic Stenosis and Severe Aortic Regurgitation

Up to 80 patients (40 aortic stenosis and 40 aortic regurgitation) at 10 sites approved for treatment in the U.S.

December 3, 2018
·
4 min read
BioMidwest

Welltower to Host Investor Day on December 4, 2018

Welltower Inc. today announced that it will host an Investor Day on Tuesday, December 4, 2018 in New York City.

December 3, 2018
·
2 min read
Biotech Beach

ALPHAEON repays outstanding principal amount under its secured convertible notes due December 23, 2018

ALPHAEON Corporation announced today that it has repaid the principal amount (approximately $56 million) of its secured convertible note obligations ahead of their December 23, 2018 maturity date.

December 3, 2018
·
1 min read
Biotech Beach

To Provide Timely, Relevant Information on the Global Opioid Epidemic, UC San Diego Extension Will Offer Fundamentals of Opiate Addiction Course in January 2019

Limited-availability online class syllabus will be geared to parents as well as front-line social services and educational providers

December 3, 2018
·
3 min read
Interim Data from the Ongoing HORIZON Trial with Melflufen Presented in an Oral Presentation at the 60th American Society of Hematology Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Professor Paul G. Richardson presented updated interim data with melflufen (Ygalo®) from the ongoing HORIZON trial at the 60th ASH meeting in San Diego, California, USA.

December 3, 2018
·
7 min read